SBI² High Content 2019

Meet InSphero imaging experts and our head of 3D plate technology and organ-on-a-chip solutions to  learn more about high content imaging applications for our 3D InSight™ platforms for drug discovery and safety testing.

• Preview the imaging capabilities of our new Akura™ 384 plates and other microtissue delivery formats, which are specifically engineered for 3D InSight™ microtissue platforms for metabolic disease and oncology
• Learn how to optimize advanced high content imaging and screening technology for 3D cell culture applications
• Hear how InSphero and Novo Nordisk are applying HCI using an islet-peripheral blood mononuclear cell (PBMC) co-culture platform
• Meet with our director of imaging strategy to discuss potential partnerships to develop imaging applications using 3D InSight™ microtissues

Judi Wardwell, our SBI² conference team leader and director of imaging strategy, will be at booth 15 and in the poster hall on Thursday. Judi is also on the board of SBI² and will be working behind the scenes of this meeting to make sure everything goes smoothly. To ensure you have time to meet with her, we highly recommend scheduling a time in advance for a one-on-one meeting.

Schedule a Meeting

This stunning image of a 3D InSight™ gastric tumor model (GFP-tagged NCI_N87 in co-culture with RFP-tagged NIH3T3 mouse fibroblasts) was visualized using the PerkinElmer, Inc. Opera Phenix™ High Content Screening System. InSphero's new Akura™ 384 plate design enhances high content imaging quality with a continuous, flat-bottom 25 µm semipermeable membrane, and eliminates fluorescent crosstalk between wells with a black-walled body. Image credit: PE Biological Applications Group, Hamburg, Germany.